Executive Insider Activity at Illumina Amid Strategic Partnerships and Analyst Upgrades
Illumina's VP and Chief Accounting Officer executed stock sales in late May. This activity occurred against a backdrop of significant corporate developments, including a collaboration with Integrated DNA Technologies to boost oncology research, the launch of new sequencing kits, and positive rating adjustments from major financial institutions.